Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22276821 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride (Adriamycin);   Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years